Medical imaging company Interlad to invest $75 million in R&D


Longtime Montreal company Interlad says it’s committing $75 million towards research and development into its own company.

Intelerad provides medical imaging business solutions and services for radiology groups, hospitals and imaging centers. The company said the $75 million investment is expected to fuel a twofold increase in study volume. Its technology already enables radiologists to perform more than 200,000 diagnostic interpretations worldwide every day.

“Medical imaging has undergone a significant transformation over the past 20 years, and Intelerad has been at the forefront of that evolution,” said CEO Paul Lepage.

“We will continue to make a difference in healthcare by delivering scalable, enterprise-wide medical imaging solutions for healthcare providers and their patients,” Lepage said.

Intelerad technology simplifies everyday tasks for radiologists and other healthcare professionals, enabling them to optimize efficiency and apply their expertise and energy toward more personalized services and follow-ups for every patient.

With an emphasis on cloud technology and artificial intelligence, Intelerad is focused on providing innovative Software as a Service (SaaS) solutions for healthcare. For example, the cloud-based Clairvoyance productivity dashboard will incorporate machine learning technology to provide predictive insights to imaging departments, enabling real time data-driven decisions that contribute to higher quality, more timely care and better outcomes for patients.

Founded in 1999 and headquartered in Montreal, Intelerad has 400 employees located in various offices in Toronto and Calgary, Seattle and Melbourne, Australia.

The company serves over 300 healthcare organizations around the world, such as hospitals, radiology groups, imaging centers, clinics and reading groups.

+ There are no comments

Add yours